Related Experiment Videos
Conditions associated with hepatocellular carcinoma
M Lisker-Melman1, P Martin, J H Hoofnagle
1Liver Diseases Section, National Institutes of Health, Bethesda, Maryland.
The Medical Clinics of North America
|July 1, 1989
Summary
Hepatocellular carcinoma (HCC) is often linked to chronic hepatitis B virus (HBV) infection. This review explores HCC
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer with significant global mortality.
- Chronic hepatitis B virus (HBV) infection is the most established risk factor for HCC.
- Understanding alternative risk factors is crucial for comprehensive HCC prevention and management.
Purpose of the Study:
- To review and synthesize current knowledge on conditions associated with hepatocellular carcinoma (HCC) beyond hepatitis B virus (HBV) infection.
- To identify and discuss non-HBV risk factors contributing to HCC development.
- To provide a consolidated resource for researchers and clinicians on diverse HCC etiologies.
Main Methods:
- Systematic literature search of relevant databases (e.g., PubMed, Scopus).
- Inclusion of studies investigating associations between various conditions and HCC.
- Synthesis and summary of findings from selected research articles.
Main Results:
- Hepatitis C virus (HCV) infection is a major non-HBV risk factor for HCC.
- Non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH), are increasingly recognized as HCC drivers.
- Other significant associations include alcohol-related liver disease, metabolic syndrome, diabetes mellitus, obesity, and certain genetic predispositions.
- Cirrhosis from any cause significantly elevates HCC risk.
Conclusions:
- While chronic HBV infection remains paramount, a growing spectrum of non-viral conditions contribute significantly to the global burden of hepatocellular carcinoma (HCC).
- The rising prevalence of metabolic and lifestyle-related factors underscores the need for broader screening and prevention strategies for HCC.
- Further research into the mechanisms underlying non-HBV-related HCC is warranted to develop targeted therapies and interventions.